Tabak O - Search Results

1

Prognostic nutritional index as indicator of immune nutritional status of patients with COVID-19.

Ekinci I, Uzun H, Utku IK, Ozkan H, Buyukkaba M, Cinar A, Akarsu M, Kumbasar A, Tabak O. Ekinci I, et al. Among authors: tabak o. Int J Vitam Nutr Res. 2022 Jan;92(1):4-12. doi: 10.1024/0300-9831/a000730. Epub 2021 Sep 20. Int J Vitam Nutr Res. 2022. PMID: 34538066

2

Hypertension and hemostatic/fibrinolytic balance disorders.

Tabak O, Gelisgen R, Uzun H, Kalender B, Balci H, Curgunlu A, Simsek G, Karter Y. Tabak O, et al. Clin Invest Med. 2009 Dec 1;32(6):E285. doi: 10.25011/cim.v32i6.10664. Clin Invest Med. 2009. PMID: 20003834

3

Oxidative lipid, protein, and DNA damage as oxidative stress markers in vascular complications of diabetes mellitus.

Tabak O, Gelisgen R, Erman H, Erdenen F, Muderrisoglu C, Aral H, Uzun H. Tabak O, et al. Clin Invest Med. 2011 Jun 1;34(3):E163-71. doi: 10.25011/cim.v34i3.15189. Clin Invest Med. 2011. PMID: 21631993

4

Circulating levels of adiponectin, orexin-A, ghrelin and the antioxidant paraoxonase-1 in metabolic syndrome.

Tabak O, Gelişgen R, Cicekçi H, Senateş E, Erdenen F, Müderrisoğlu C, Aral H, Uzun H. Tabak O, et al. Minerva Med. 2012 Aug;103(4):323-9. Minerva Med. 2012. PMID: 22805624

5

Effects of peritoneal-and hemodialysis on levels of plasma protein and lipid oxidation markers in diabetic patients.

Sozer V, Korkmaz Guntas G, Konukoglu D, Dervisoglu E, Gelisgen R, Tabak O, Kalender B, Uzun H. Sozer V, et al. Among authors: tabak o. Minerva Med. 2013 Feb;104(1):75-84. Minerva Med. 2013. PMID: 23392540

6

The association of oxidative stress markers with conventional risk factors in the metabolic syndrome.

Korkmaz GG, Altınoglu E, Civelek S, Sozer V, Erdenen F, Tabak O, Uzun H. Korkmaz GG, et al. Among authors: tabak o. Metabolism. 2013 Jun;62(6):828-35. doi: 10.1016/j.metabol.2013.01.002. Epub 2013 Feb 11. Metabolism. 2013. PMID: 23410746

7

Plasma ghrelin, leptin, and orexin-A levels and insulin resistance after laparoscopic gastric band applications in morbidly obese patients.

Cigdem Arica P, Kocael A, Tabak O, Taskin M, Zengin K, Uzun H. Cigdem Arica P, et al. Among authors: tabak o. Minerva Med. 2013 Jun;104(3):309-16. Minerva Med. 2013. PMID: 23748284

8

Diagnostic and prognostic value of tumor M2-pyruvate kinase levels in patients with colorectal canhcer.

Demır AS, Erdenen F, Müderrısoğlu C, Toros AB, Bektaş H, Gelışgen R, Tabak Ö, Altunoğlu E, Uzun H, Erdem Huq GE, Aral H. Demır AS, et al. Among authors: tabak o. Turk J Gastroenterol. 2013;24(1):36-42. Turk J Gastroenterol. 2013. PMID: 23794342 Free article.

9

The effects of atorvastatin on oxidative stress in L-NAME-treated rats.

Sozer V, Uzun H, Gelisgen R, Kaya M, Kalayci R, Tabak O, Arican N, Konukoglu D. Sozer V, et al. Among authors: tabak o. Scand J Clin Lab Invest. 2013 Oct;73(7):591-7. doi: 10.3109/00365513.2013.828241. Epub 2013 Sep 12. Scand J Clin Lab Invest. 2013. PMID: 24024670

10

Evaluation of serum paraoxonase and arylesterase activities in subjects with asthma and chronic obstructive lung disease.

Acay A, Erdenen F, Altunoglu E, Erman H, Muderrisoglu C, Korkmaz GG, Gelisgen R, Tabak O, Uzun H. Acay A, et al. Among authors: tabak o. Clin Lab. 2013;59(11-12):1331-7. doi: 10.7754/clin.lab.2013.121144. Clin Lab. 2013. PMID: 24409668

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

55 results

Search Page